Fmr LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Fmr LLC holds 148,045 shares of DNA stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148,045

Previous 25,906 471.47%

Holding current value

$1.26 Million

Previous $30,000 60.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $34,198 - $141,681	122,139 Added 471.47%	148,045 $48,000
Q1 2024 May 13, 2024	SELL	$1.06 - $1.67 $1.1 Million - $1.73 Million	-1,035,290 Reduced 97.56%	25,906 $30,000
Q4 2023 Feb 13, 2024	SELL	$1.26 - $1.79 $167,330 - $237,715	-132,802 Reduced 11.12%	1,061,196 $1.79 Million
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $987,479 - $1.56 Million	-613,341 Reduced 33.94%	1,193,998 $2.16 Million
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $206,938 - $353,973	181,525 Added 11.17%	1,807,339 $3.36 Million
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $987,326 - $1.8 Million	-822,772 Reduced 33.6%	1,625,814 $2.16 Million
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $1.38 Million - $2.98 Million	847,729 Added 52.95%	2,448,586 $4.14 Million
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $288,871 - $1.48 Million	395,715 Added 32.84%	1,600,857 $5 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $2.65 Million - $5.06 Million	1,204,982 Added 753113.75%	1,205,142 $2.87 Million
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $452 - $1,390	160 New	160 $1,000

Others Institutions Holding DNA

# of Institutions

209

Shares Held

716M

Call Options Held

990K

Put Options Held

2.23M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.9B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account